Path 3 from C00279,C00074 to C00079

Back to all pathways

Sources: D-Erythrose 4-phosphate (C00279) Phosphoenolpyruvate; (C00074)

Target:L-Phenylalanine; (C00079)

Z: 1.0
Composite map: C00279->C00079:[10->7,6->3,7->6,8->10], C00074->C00079:[6->1,6->5,7->8,8->2,8->4]

Showing 1 best reactions for each rpair.

RPAIRReactionScoreSeq1Seq2EvalueECsEquation
RP01568R01518452TRIRE0077656Q747Q8|GPMI_GEOSL e-1275.4.2.1 2-Phospho-D-glycerate; <=> 3-Phospho-D-glycerate;
RP01711R01715234TRIRE0120219P32178|CHMU_YEAST 2e-615.4.99.5 Chorismate; <=> Prephenate;
RP00057R00694511TRIRE0005233P05202|AATM_MOUSE e-1442.6.1.1 2-Oxoglutarate; + L-Phenylalanine; <=> L-Glutamate; + Phenylpyruvate;
RP13340R01827443TRIRE0123026O42700|TAL1_SCHPO e-1242.2.1.2 Sedoheptulose 7-phosphate; + D-Glyceraldehyde 3-phosphate; <=> D-Erythrose 4-phosphate + beta-D-Fructose 6-phosphate
RP01790R01830931TRIRE0120635Q12630|TKT1_KLULA 0.02.2.1.1 D-Glyceraldehyde 3-phosphate; + beta-D-Fructose 6-phosphate <=> D-Xylulose 5-phosphate + D-Erythrose 4-phosphate
RP00113R01512801TRIRE0021406P14228|PGK_TRIRE 0.02.7.2.3 3-Phospho-D-glycerate; + ATP; <=> 3-Phospho-D-glyceroyl phosphate; + ADP;
RP02189R024121637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 ATP; + Shikimate; <=> Shikimate 3-phosphate; + ADP;
RP00577R024131637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 NADP+; + Shikimate; <=> NADPH; + 3-Dehydroshikimate + H
RP01465R01373158TRIRE0080151O67085|PHEA_AQUAE 1e-385.4.99.5,4.2.1.51 Prephenate; <=> CO2; + Phenylpyruvate; + H2O;
RP01785R01826706TRIRE0078347P80576|AROF_NEUCR 0.02.5.1.54 H2O; + D-Erythrose 4-phosphate + Phosphoenolpyruvate; <=> Orthophosphate; + 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;
RP01710R01714535TRIRE0023298Q12640|AROC_NEUCR e-1524.2.3.5 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; <=> Chorismate; + Orthophosphate;
RP03070R034601637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 Phosphoenolpyruvate; + Shikimate 3-phosphate; <=> 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; + Orthophosphate;
RP02750R030841637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 3-Dehydroquinate; <=> 3-Dehydroshikimate + H2O;
RP01033R00658777TRIRE0120568Q76KF9|ENO_PENCH 0.04.2.1.11 2-Phospho-D-glycerate; <=> H2O; + Phosphoenolpyruvate;
RP01784R01826706TRIRE0078347P80576|AROF_NEUCR 0.02.5.1.54 H2O; + D-Erythrose 4-phosphate + Phosphoenolpyruvate; <=> Orthophosphate; + 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate;
RP03071R034601637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 Phosphoenolpyruvate; + Shikimate 3-phosphate; <=> 5-O-(1-Carboxyvinyl)-3-phosphoshikimate; + Orthophosphate;
RP00395R01061612TRIRE0119735P17730|G3P2_TRIKO e-1751.2.1.12 NAD+; + D-Glyceraldehyde 3-phosphate; + Orthophosphate; <=> NADH; + 3-Phospho-D-glyceroyl phosphate; + H
RP02749R030831637TRIRE0082516P07547|ARO1_EMENI 0.04.2.3.4,2.5.1.19,2.7.1.71,4.2.1.10,1.1.1.25 2-Dehydro-3-deoxy-D-arabino-heptonate 7-phosphate; <=> Orthophosphate; + 3-Dehydroquinate;

Pathway diagram (see pathway with molecule structures instead)